Search results
AstraZeneca posts mixed results from recent Imfinzi trials
ShareCast· 21 hours agoAstraZeneca announced contrasting results from two phase three trials involving its immunotherapy...
AstraZeneca still a buy for one broker despite mixed Imfinzi data
Proactive Financial News· 14 hours agoAstraZeneca PLC (LSE:AZN) has put out mixed data for the Phase III trials of its immuno-oncology...
TOP NEWS: AstraZeneca details mixed findings from cancer drug trials
Morningstar· 17 hours agoShares in AstraZeneca rose 0.6% to 12,548.00 pence on Tuesday morning. The Cambridge-based pharmaceutical company said Imfinzi met both its primary and secondary aims in a trial on sufferers of bladder cancer.
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance UK· 15 hours agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers
Reuters via Yahoo Finance UK· 23 hours agoImfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen...
AstraZeneca announces positive bladder cancer trial results, Landsec raises Bluewater stake
ShareCast· 23 hours agoThe FTSE 100 is expected to open 13 points lower on Tuesday, having closed up 0.53% on Monday at 8,281.55. AstraZeneca announced on Tuesday that a recent trial revealed that ...
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks via Yahoo Finance UK· 6 days agoThe European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 1 hour agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
1 heavyweight FTSE 100 share I’d buy as London retakes its crown
Fool.co.uk via Yahoo Finance UK· 6 days agoSome Footsie firms are extremely large, but that doesn't mean they couldn't get even bigger. Here's...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 1 day ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...